Rocky Mountain Cancer Center — Boulder, Colorado

Rocky Mountain Cancer Center is a clinical research site located in Boulder, Colorado, United States.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Center has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: Prostate Cancer, Early Breast Cancer, Primary Myelofibrosis.

Sponsors: Achieve Life Sciences, ETOP IBCSG Partners Foundation, CTI BioPharma.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Center?

Rocky Mountain Cancer Center has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Center conducted?

Rocky Mountain Cancer Center has 6 clinical trials on record, with 1 currently active. Their work covers Prostate Cancer, Early Breast Cancer, Primary Myelofibrosis.

Is Rocky Mountain Cancer Center accredited by Crixeo Health?

Yes — Rocky Mountain Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Rocky Mountain Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.